Pharma

Your Article Summary

See Latest Articles

GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
GlaxoSmithKline, 10/14/09

GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, announced that they have entered into an exclusive worldwide collaboration for the development and commercialisation of RNA based therapeutics for Duchenne Muscular Dystrophy (DMD). DMD is a severely debilitating childhood neuromuscular disease that affects one in 3,500 newborn boys.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Carillion to install bedside terminals at LHSC
Canadian Healthcare Technology, 11/20/09

Vendor Partnership Targets HIEs
HealthDataManagement, 11/20/09

Consultancy, Open Source Firm Target HIEs
HealthDataManagement, 11/20/09

 See all of M&A/Partnerships